Pathstone Holdings, LLC Macrogenics Inc Transaction History
Pathstone Holdings, LLC
- $22.2 Billion
- Q4 2024
A detailed history of Pathstone Holdings, LLC transactions in Macrogenics Inc stock. As of the latest transaction made, Pathstone Holdings, LLC holds 11,281 shares of MGNX stock, worth $25,269. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,281
Previous 15,894
29.02%
Holding current value
$25,269
Previous $52,000
30.77%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding MGNX
# of Institutions
131Shares Held
56MCall Options Held
28.3KPut Options Held
197K-
Bellevue Group Ag Kuesnacht, V89.93MShares$22.2 Million0.64% of portfolio
-
Armistice Capital, LLC New York, NY6.28MShares$14.1 Million0.29% of portfolio
-
Black Rock Inc. New York, NY5.4MShares$12.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.32MShares$9.67 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.49MShares$7.81 Million0.06% of portfolio
About MACROGENICS INC
- Ticker MGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,458,800
- Market Cap $138M
- Description
- MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...